Avadel Pharmaceuticals (AVDL) Interest & Investment Income: 2014-2020
Historic Interest & Investment Income for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Dec 2020 value amounting to $74,000.
- Avadel Pharmaceuticals' Interest & Investment Income rose 105.00% to $74,000 in Q4 2020 from the same period last year, while for Dec 2020 it was -$1.6 million, marking a year-over-year decrease of 246.87%. This contributed to the annual value of -$832,000 for FY2020, which is 177.83% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Interest & Investment Income stood at $74,000 for Q4 2020, which was down 65.26% from $213,000 recorded in Q3 2020.
- Avadel Pharmaceuticals' Interest & Investment Income's 5-year high stood at $977,000 during Q3 2017, with a 5-year trough of -$1.5 million in Q4 2019.
- In the last 3 years, Avadel Pharmaceuticals' Interest & Investment Income had a median value of $208,000 in 2018 and averaged $130,000.
- Examining YoY changes over the last 5 years, Avadel Pharmaceuticals' Interest & Investment Income showed a top increase of 1,412.96% in 2019 and a maximum decrease of 276.34% in 2019.
- Over the past 5 years, Avadel Pharmaceuticals' Interest & Investment Income (Quarterly) stood at $555,000 in 2016, then crashed by 48.11% to $288,000 in 2017, then plummeted by 236.46% to -$393,000 in 2018, then plummeted by 276.34% to -$1.5 million in 2019, then surged by 105.00% to $74,000 in 2020.
- Its Interest & Investment Income was $74,000 in Q4 2020, compared to $213,000 in Q3 2020 and -$378,000 in Q2 2020.